Updates on Vaccine-Preventable Respiratory Viral Infections in Pediatric Solid Organ Transplant Recipients
Updates on Vaccine-Preventable Respiratory Viral Infections in Pediatric Solid Organ Transplant Recipients

Updates on Vaccine-Preventable Respiratory Viral Infections in Pediatric Solid Organ Transplant Recipients

Pediatr Transplant. 2025 Dec;29(8):e70231. doi: 10.1111/petr.70231.

ABSTRACT

The global burden of acute lower respiratory tract infections, including viral etiologies, equated to 725 557 deaths in 2021 in children under 4 years of age. Community-acquired respiratory viral infections (RVI) also carry a high burden among pediatric solid organ transplant recipients (PSOTR), accounting for 14.5% of hospitalizations in the first year post-transplant in an American cohort. This mini review on behalf of the International Pediatric Transplant Association (IPTA) infectious diseases committee discusses novel preventative and prophylactic strategies and includes pertinent updates for vaccine-preventable RVI including influenza, SARS-CoV-2, and RSV in PSOTR.

PMID:41276789 | DOI:10.1111/petr.70231